<i>ABCB1</i> mRNA levels increase initially in imatinib and dasatinib resistant cell lines but decrease following emergence of additional resistance mechanisms. by Laura N. Eadie (3044079)

Unique Biofilm Signature, Drug Susceptibility and Decreased Virulence in <em>Drosophila</em> through the <em>Pseudomonas aeruginosa</em> Two-Component System PprAB by Sophie de Bentzmann (116508)

Decreased proliferation in <i>Csf1r^−/−</i> and <i>Csf1^op/op</i> mouse colonic epithelium. by Duy Huynh (381445)

“…(<b>B</b>) Enumeration of the total number of positively stained nuclei reveals that average number of proliferating cells/crypt is significantly reduced in proximal (left panel) and distal (right panel) colons of <i>Csf1^op/op</i> and <i>Csf1r^−/−,</i> compared to WT, mice. Bar = 50 µm (n = 3). (<b>C</b>) Staining with the G₂/M phase marker, phosphorylated histone H3 (PH-3, black arrows) also shows decreased numbers of cells in cycle per crypt in both mutants. …”

Data from Queiroz et al Ant diversity decreases during the dry season: a meta-analysis of the effects of seasonality on ant richness and abundance.xlsx by Antonio Queiroz (12529531)

Salinomycin decreases the CD44⁺/CD24^- stem-like population during anchorage-independent growth and inhibits mammosphere formation. by Hyunsook An (821121)

<i>Fgfr2^+/S252W</i> mice had shortened bone length and decreased bone mass compared with wild-type mice. by Peng Chen (6514)

“…<p>(A–F) X-ray analyses of femora, tibia and lumbar vertebrae from WT and MT mice at P5 (A, B), P10 (C, D) and P28 (E, F) revealed shorter bone length and lower bone density in mutant mice. …”

ZC3H11 depletion decreases the <i>HSP70</i> mRNA level and this effect requires the AU-rich sequence in the 3′-UTR. by Dorothea Droll (399073)

SrpR binds the centromere-like region <i>srpC</i>. by Nicolas Carraro (650366)

Dynamics and structural stability effects of germline <i>PTEN</i> mutations associated with cancer versus autism phenotypes by Iris Nira Smith (5215259)

Corn gluten meal induces enteritis and decreases intestinal immunity and antioxidant capacity in turbot (<i>Scophthalmus maximus</i>) at high supplementation levels - Fig 2 by Nan Bai (1576645)

“…</b> (a–d) Representative images of decreased height and increased fusion of the mucosal folds with increasing corn gluten meal level (bar = 500 <b>μ</b>m). …”

Knockout of <i>slhA</i> and <i>hag</i> decreases biofilm formation of <i>P. alvei</i> CCM 2051^T cells. by Bettina Janesch (322847)

Transfer of IgG from immune mice decreases CTL numbers and anti-Gag IgG Abs in offspring immunized with <i>LAMP/gag</i>. by Paula Ordonhez Rigato (183494)

Age-stage specific survival rate (<i>s</i>_<i>xj</i>) of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

Age-stage-specific survival rate (<i>s</i>_<i>xj</i>) of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

Insights from the Fungus <em>Fusarium oxysporum</em> Point to High Affinity Glucose Transporters as Targets for Enhancing Ethanol Production from Lignocellulose by Shahin S. Ali (277910)

miR-17-92 expression correlates with ETS transcription factors Spi-1 and Fli-1 decrease during 745A#44 cells differentiation. by Samer Kayali (133888)

Discovery and Pharmacological Studies of 4‑Hydroxyphenyl-Derived Phosphonium Salts Active in a Mouse Model of Visceral Leishmaniasis by José Ignacio Manzano (7908449)

“…Disruption of the energetic metabolism, with a decrease of intracellular ATP levels as well as mitochondrial depolarization together with a significant reactive oxygen species production, contributes to the leishmanicidal effect of <b>1</b>. …”

Effectiveness of the available COVID-19 primary and booster vaccination schemes against laboratory-confirmed infections during the different waves. by Rima Moghnieh (679199)

Subjects:

Effectiveness of the available COVID-19 primary and booster vaccination schemes against acute-care hospitalization attributed to laboratory-confirmed infections during the differen... by Rima Moghnieh (679199)

Subjects:

Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. by Rima Moghnieh (679199)

Subjects: